U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Did You Know...

...that the first rickshaw was invented in 1869 by an American Baptist minister, the Rev. E. Jonathan Scobie, to transport his invalid wife around the streets of Yokohama?

Newsletter  PatentStorm News

Make the Most of PatentStorm

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest patents by subscribing to an RSS feed.

Got questions? Ask a Patent Expert!

Registered users: Manage your profile, comments and alerts.

 

US Patent 6235725 - Methods and compositions for the prevention of tolerance to medications

US Patent Issued on May 22, 2001
Estimated Patent Expiration Date: Icon_subject July 28, 2019Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
loading...


View Patent Images (PDF)
(Registered users only)

Abstract

The present invention pertains to the identification of moieties and methods of using the same for preventing tolerance to bronchodilators. More specifically, the present invention pertains to the identification of compositions and methods which are capable of preventing tolerance to 댢 -adrenergic agonists. The methods and compositions according to the invention are also useful as analytical tools for functional studies and as combination therapeutic tools.

Other References

  • Sheffer, et al. (1993) Med. Care 31:MS20
  • Am. Rev. Respir. Dis. (1987) 136:225-244
  • Hargreave, et al. (1986) J. Allergy Clinical Immunol. 83:1013-1026
  • Fuci, et al. (1998) Harrison's Principals of Internal Medicine 14th Ed., pp. 1419-1426
  • Barnes, et al. (1990) Am. Rev. Respir. Dis. 141:S70-S76
  • Woolock, et al. (1996) Am. Respir, Crit, Care. 153:1481-1488
  • Volcheck, et al. (1998) Postfrad Med. 104(3):127-136
  • Palmer, et al. (1994) New Eng. J. Med. 331:1314-1319
  • Bhagat, et al. (1995) Chest 108: 1235-1239
  • Lipworth, et al. (1995) Lancet 346:201-206
  • Woolcock (1995) Eur. Respir. Rev. 5:(27)142-145
  • Kalra, et al. (1996) Chest 109:953-56
  • Hausdorff, et al. (1990) FASEB J 4:2881-2889
  • Liggert, et al. (1992) J. Biol. Chem. 267:4740-4746
  • Schlelricher, et al. (1993) Proc. Nat'l. Acad. Sci. USA 90:1420-1427
  • Turki et al. (1995) Am. Physiol. 269(13):L709-L714
  • Ahmed, et al. (1992) Am. Rev. Respir. Dis. . 145:566-570
  • Lucio, et al. (1992) Amer. Physiol Soc. 73(3):1093-1101
  • Ahmed, et al. (1993) N. Eng. J. Med. 329:90-95
  • Ahmed, Respiratory Drug Delivery IV, 55-63
  • Lane, et al. (1989) Chemical and Biological Properties, Clinical Applications
  • Goodwin & Gilman (1996) The Pharmacological Basis of Therapeutics, 9th Ed
  • Harrison's i Supraat pp. 1167-1176
  • Goodman's & Gilman's Supra at pp. 664-665
  • Goodman's & Gilman's supsra at Chapter 7
  • Fisher and Tiemann (1984) Ber Dtsch. Chem. Ges. 27:138-147
  • Foster Chem. Ind.627 (1955) and Shively and Conrad (1976) Biochemistry 15:3932-3942
  • Linker, et al. (1972) Methods of Enzymology, Ginbsurg Ed., Academic Press, New Yorks pp. 902-911
  • Remington's Pharmaceutical Sciences (1990) 18th., Ed., Gennaro, Mack Publishing Co., Easton PA
  • Remington: The Science and Practice of Pharmacy (1995) Lippincott, Williams & Wilkin

Inventor

Assignee

Application

No. 362540 filed on 07/28/1999

US Classes:

514/56, Heparin or derivative514/23, Carbohydrate (i.e., saccharide radical containing) DOAI514/53, Dissacharide514/54, Polysaccharide514/653, Hydroxy, bonded directly to carbon, attached directly or indirectly to the acyclic carbon or chain by acyclic nonionic bonding (e.g., beta hydroxy phenethylamines, etc.)514/826ASTHMA

Field of Search

514/53, Dissacharide514/54, Polysaccharide514/56, Heparin or derivative514/653, Hydroxy, bonded directly to carbon, attached directly or indirectly to the acyclic carbon or chain by acyclic nonionic bonding (e.g., beta hydroxy phenethylamines, etc.)514/826, ASTHMA514/23Carbohydrate (i.e., saccharide radical containing) DOAI

Examiners

Primary: Peselev, Elli

Attorney, Agent or Firm

US Patent References

4933326, Oligosaccharides obtained by heparin depolymerization having antiatherosclerotic activity
Issued on: 06/12/1990
Inventor: Bianchini, et al.
5032679, Heparin fragments as inhibitors of smooth muscle cell proliferation
Issued on: 07/16/1991
Inventor: Brandley, et al.
5049389, Novel liposome composition for the treatment of interstitial lung diseases
Issued on: 09/17/1991
Inventor: Radhakrishnan
5192548, Device
Issued on: 03/09/1993
Inventor: Velasquez, et al.
5380716, Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation
Issued on: 01/10/1995
Inventor: Conrad, et al.
5674860, Combination of a bronchodilator and a steroidal anti-inflammatory drug for the treatment of respiratory disorders
Issued on: 10/07/1997
Inventor: Carling, et al.
5709884, Process for conditioning substances
Issued on: 01/20/1998
Inventor: Trofast, et al.
5714376, Heparinase gene from flavobacterium heparinum
Issued on: 02/03/1998
Inventor: Sasisekharan, et al.
5736124, Aerosol formulations containing P134a and particulate medicament
Issued on: 04/07/1998
Inventor: Akehurst, et al.
5817293, Canister containing aerosol formulations containing P134a and particulate medicaments
Issued on: 10/06/1998
Inventor: Akehurst, et al.
5874063Pharmaceutical formulation
Issued on: 02/23/1999
Inventor: Briggner, et al.

International Class

A61K 031/70

Comments

No comments for this page
 
 
Forgot password?
Register here